Gender bias in drug dosage trials and overmedicated women


A new study from the journal Biology of Sex Differences found an association between sex biases in drug dosage trials and the overmedication of women.

According to investigators, women are more likely than men to experience adverse drug reactions from medications, as clinical trials have historically focused on men.

In the August issue of Contemporary OB/GYN, Editor-in-Chief Dr. Catherine Y. Spong discussed the ways in which women’s health research has and continues to be marginalized. Read her full editorial here.

“Only in 1993, with the passage of the National Institutes of Health Revitalization Act, were women mandated to be included in NIH-funded research,” wrote Dr. Spong.

For additional details on the study’s findings, visit our sister publication, Drug Topics.

Recent Videos
The significance of the Supreme Court upholding mifepristone access | Image Credit:
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit:
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit:
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit:
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit:
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit:
raanan meyer, md
© 2024 MJH Life Sciences

All rights reserved.